Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN394126 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interferon, gamma-Inducible Protein 16 (IFI16) antibody
- Antibody type
- Monoclonal
- Antigen
- IFI16 (AAH17059, 630 a.a. ~ 730 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 K
- Description
- Purified
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- 2C2
- Vial size
- 0.05 mg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Delta-like 1 contributes to cell growth by increasing the interferon-inducible protein 16 expression in hepatocellular carcinoma.
Association of IFI200 gene polymorphisms with susceptibility to systemic lupus erythematosus.
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein.
Yu F, Hao X, Zhao H, Ge C, Yao M, Yang S, Li J
Liver international : official journal of the International Association for the Study of the Liver 2010 May;30(5):703-14
Liver international : official journal of the International Association for the Study of the Liver 2010 May;30(5):703-14
Association of IFI200 gene polymorphisms with susceptibility to systemic lupus erythematosus.
Kimkong I, Avihingsanon Y, Hirankarn N
The Journal of rheumatology 2010 Jul;37(7):1544-7
The Journal of rheumatology 2010 Jul;37(7):1544-7
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR
Molecular medicine (Cambridge, Mass.) 2010 Jul-Aug;16(7-8):247-53
Molecular medicine (Cambridge, Mass.) 2010 Jul-Aug;16(7-8):247-53
Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot".
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude J, Wang-Gohrke S, Cramer DW, Terry KL, Hankinson SE, Tworoger SS, Garcia-Closas M, Yang H, Lissowska J, Chanock SJ, Pharoah PD, Song H, Whitemore AS, Pearce CL, Stram DO, Wu AH, Pike MC, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Anton-Culver H, Ziogas A, Hogdall E, Kjaer SK, Hogdall C, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Phelan CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G, Ovarian Cancer Association Consortium, Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer)
PLoS genetics 2010 Jul 8;6(7):e1001016
PLoS genetics 2010 Jul 8;6(7):e1001016
Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein.
Cristea IM, Moorman NJ, Terhune SS, Cuevas CD, O'Keefe ES, Rout MP, Chait BT, Shenk T
Journal of virology 2010 Aug;84(15):7803-14
Journal of virology 2010 Aug;84(15):7803-14
No comments: Submit comment
No validations: Submit validation data